✦ LIBER ✦

Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn’s disease

✍ Scribed by R. PANACCIONE; J.-F. COLOMBEL; W. J. SANDBORN; P. RUTGEERTS; G. R. D’HAENS; A. M. ROBINSON; J. CHAO; P. M. MULANI; P. F. POLLACK

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adalimumab sustains steroid-free remissi

✍ M. A. Kamm; S. B. Hanauer; R. Panaccione; J.-F. Colombel; W. J. Sandborn; P. F. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

Sustained Clinical Benefit and Tolerabil

✍ Seinen, Margien L.; Ponsioen, Cyriel Y.; de Boer, Nanne K.H.; Oldenburg, Bas; Bo 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 467 KB

Adalimumab for the induction and mainten

✍ Mamoru Watanabe; Toshifumi Hibi; Kathleen G. Lomax; Susan K. Paulson; Jingdong C 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 813 KB

Adalimumab for Maintenance of Clinical R

✍ Jean–Frédéric Colombel; William J. Sandborn; Paul Rutgeerts; Robert Enns; Stephe 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 712 KB

Adalimumab in Steroid-Dependent Crohn's

✍ Orlando, Ambrogio ;Renna, Sara ;Mocciaro, Filippo ;Cappello, Maria ;Di Mitri, Ro 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Adalimumab is safe and effective in re-i

✍ Flavio Caprioli; Chiara Viganò; Fiorenzo Botti; Ettore Contessini-Avesani 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 807 KB